Friday , November 15 2019
Home / BUSINESS / JB Chemicals gets USFDA’s nod for Midodrine Hydrochloride Tablets

JB Chemicals gets USFDA’s nod for Midodrine Hydrochloride Tablets

JB Chemicals & Pharmaceuticals (JBCPL) has received an approval from the US Food and Drug Administration (USFDA) for Abbreviated New Drug Application (ANDA) for Midodrine Hydrochloride Tablets USP 2.5 mg, 5 mg and 10 mg. (for treatment of orthostatic hypotension).

The company plans to commercialize this product in Q1 of next financial year and is expected to boost company’s US sales. The company is focused on US business and this approval will help company grow its exports.

JB Chemicals & Pharmaceuticals (JBCPL) is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).